Clinical Engagement = Clinical Translation But how do I engage? | 26 May 2022 – 2.00pm-3.00pm @ KG-Q430 Seminar Room – Zoom meeting ID: 882 7058 7097, Password: CBT Registrations essential
Welcome to the first in a series of seminars designed to assist CB researchers develop relationships with clinicians. In this seminar we will hear from 3 research leaders from CBT, who all have significant, impactful and well established collaborations with clinical partners, from varying fields of clinical practise. In listening to their journey and experiences in developing strong clinical partnerships, we hope you will learn how to go about engaging with clinicians, and how to enhance your research translation into clinical application.
CBT Industry Engagement Q&A Series – Session 3 | 3 May 2022
Commercialisation and industry engagement are becoming an increasingly more necessary skill in scientists’ careers. It is now vital to be aware of the opportunities but also of the challenges and risks associated. This workshop, part of the Q&A sessions cycle with the QUT Industry Engagement Office, provided clear concrete, and practical answers to the real needs of the researchers.
Realistic performance prediction of advanced AM structures | 27th April 2022
Advanced lattices and gyroids manufactured by additive manufacturing processes are inherently suitable for applications in the MedTech sector, but have complex mechanical characteristics due to many fine-featured structural elements. Finite element analysis approaches of the as-designed (perfect) structure generally over-predict the determined experimental properties (stiffness, yield) due to inherent defects within the printed structure. X-ray tomography with defect mapping can bridge this gap and aid in our understanding and avoidance of defect-sensitive designs. In addition, stochastic information about defect distributions can be derived from X-ray tomography and can be utilised to determine the scatter in performance, hence increasing our confidence in the predicted mechanical performance.
Next-Generation Therapeutic Strategies for Osteoarthritis (OA) | 23rd February 2022
3D Printing of Biomaterials for Replacement and Regeneration for Orthopedic Applications
Associate Professor Chatterjee is an Associate Editor for RSC Advances and an editorial board member for Biomacromolecules, ACS Applied Biomaterials, In Vitro Models, and Frontiers in Medical Technology journals. In this seminar, he discusses 3D printing and additive manufacturing technologies which have emerged in recent years to offer unique opportunities for the processing of materials for biomedical applications.
The seminar will describe the work on selective laser melting (SLM) of titanium alloys where unique heat treatment of the parts prepared by SLM was developed to improve the biomechanical performance of the as-manufactured parts and was further adopted for preparing patient-specific implants as part of an ongoing clinical trial. Fused filament fabrication (FFF) offers an affordable and simple route to prepare 3D tissue scaffolds from biodegradable polymers and coating the 3D printed scaffolds with bioactive ceramics was found to be critical to improving the cellular response toward bone tissue regeneration. Digital light projection (DLP)-based 3D bioprinting can be used to prepare cell-laden hydrogels. Photopolymerizable bioinks were used to prepare scaffolds that can faithfully mimic the architecture of bone tissues seen in vivo. Taken together, this talk will highlight how biomaterials processed by 3D printing can be developed for clinical use in orthopedics.
Next-Generation Therapeutic Strategies for Osteoarthritis (OA) | 23rd February 2022
Dr Indira Prasadam is a Senior Lecturer in Biomedical Engineering at Queensland University of Technology and an National Health and Medical Research Council (NHMRC) Emerging Leadership Fellow. Her main research contribution has been in the development of novel disease-modifying and regenerative treatments, as well as pain management technology, to improve the quality of life of the millions of individuals who suffer from OA. Her work has been widely published, and she has received awards from a number of international and Australian professional organisations. Young Investigator Award from OARSI, Young Tall Poppy Award, Women in Technology (WiT) Rising Star (Finalist), and Metro-north Discovery and Innovation Award are among the notable accolades earned. Her current study is funded by the NMHRC, the Australian Research Council (ARC), the Australian Orthopedic Foundation, Queensland University of Technology, and the Prince Charles Hospital Foundation.
Bioinspiration, architecture, and 3D-4D printing for the next-generation materials | 23rd March 2022
Mohammad Mirkhalaf is a Lecturer and ARC DECRA fellow at the Queensland University of Technology (QUT). His research is on tailoring material’s internal architecture to improve its mechanical properties and tissue regeneration capacity. He has published 26 original research articles and one invited review article in high-profile journals, two book chapters, a full US patent, and two patents at the corporation treaty stage. Of the journal articles, he is the first author on 17; these include publications in leading multidisciplinary journals such as Nature Communications, PNAS, Acta Biomaterialia, and Appl Mater Today and in leading disciplinary journals in mechanics (e.g., Extreme Mechanics Letters & Int J Solids Struct). He has been the first-named investigator on four successful external grant applications (worth > A$1M) and attracted several prestigious postdoctoral/graduate awards (total > A$500K). His experience working at universities, government labs, and industries in Iran, Singapore, Canada, and recently Australia has enabled him to build solid national and international research partnerships. He has developed and taught two new courses at the University of Sydney, and taught graduate and undergraduate courses McGill University, and Nanyang Technological University.
ARC DECRA and Future Fellowship seminar – Maximise your chance for success | 16th September 2021
Professor Axel Bruns has successfully secured over $68 million in research funding. He is a previous ARC Future Fellow and was a named Chief Investigator on the Centre of Excellence for Creative Industries and Innovation. Further he has led or was a named Chief Investigator on five successful Linkage Projects as well as three successful Discovery Projects.
Axel is an Australian Research Council Laureate Fellow and Professor in the Digital Media Research Centre at Queensland University of Technology in Brisbane, Australia, and a Chief Investigator in the ARC Centre of Excellence for Automated Decision-Making and Society..
Journey from lab to clinical guideline: Digital Pathology + AI in liver disease diagnosis and treatment | 24th August 2021
Dr Dean Tai, Co-founder and Chief Scientific Officer (CSO) of HistoIndex, will talk about the translation of an innovative microscopy imaging system into new clinical trial guidelines for new drugs targeting liver diseases. Several aspects of this translation path will be discussed. Technically, what does it take to take a AI based imaging system from laboratory to industrial manufacturing? How to identify and enter the market? And how do you gain endorsements from key option leaders and business leaders in a specific disease domain?
Dr Tai will also be sharing his experiences over the commercialisation path and his personal journey transiting from being a physicist and post-doctoral researcher to a businessman involved in managing companies in Australia, Singapore, China and USA.
Machine Learning Explainer | 28th June 2021
CBT and School of MMPE brings together QUT staff and students to learn and discuss the opportunities of applying Machine Learning (ML) in their research disciplines. The aim is to encourage an informal and inclusive atmosphere to encourage questions and participation, as well as being highly informative on available resources for learning and upskilling of ML.
A/Prof Yi-Chin Toh, Academic Lead (Research) at School of MMPE, will facilitate a panel of ML experts in a discussion about what you should know when seeking resources and aligning your research to ML.
A novel 3D printing approach for structured microenvironments and defined cell behaviour | 24th May 2021
Hala Zreiqat AM, is a professor of biomedical engineering at the University of Sydney and both a National Health and Medical Research Council Senior Research Fellow (2006-2020); Director ARC Training Centre for Innovative Bio-Engineering. She is an Associate of the John A. Paulson School of Engineering and Applied Sciences, Harvard University, Honorary Professor Shanghai Jiao Tong University.
Her research is on the development of novel engineered materials and 3D-printed and nanotechnology platforms, in orthopaedic, dental, and maxillofacial applications. Her group is also developing effective biological approaches through biochemical and cellular modification for the repair and regenerating of large bone defects and non-union bone fractures.
Development of a high resolution 3D printing technology for advanced biomaterials | 14th April 2021
Paul Dalton is an Associate Professor at the Phil and Penny Knight Campus at the University of Oregon, USA, and has over 25 years’ of interdisciplinary experience with biomedical materials, including polymer processing, experimental surgery, nanotechnology and hydrogels. This interdisciplinary background has been achieved at numerous institutions, including Lions Eye Institute (Australia), University of Toronto (Canada), RWTH Aachen (Germany), University of Southampton (UK), Shanghai Jiao Tong University (China) and University of Würzburg (Germany).
He commenced work on melt electrospinning in 2003, and developed this into a direct-writing technology at QUT from 2009, with particularly utility for the manufacture of biomedical materials
Research translation and commercialisation in the post COVID world | 8th April 2021
Associate Professor Tam Nguyen has over 20 years of working in the healthcare, health and medical research and research management sector including tertiary teaching hospitals, medical research institutes and universities across Australia.
As the deputy director of research at St Vincent’s Hospital Melbourne, Tam is responsible for research strategy, research development and innovation. He leads a dynamic team dedicated to providing strategic and innovative solutions to facilitate health and medical research. Tam serves as non-executive director on various NFP, healthcare and aged care boards providing his broad range expertise including strategy, governance, and sector specific in health and medical research.
He also advises numerous medtech and health tech start-ups on their overall strategies, clinical trials strategies, project management and execution.